|
SASH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.34481314972845E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.33961763693469E-12 |
| Normal-vs-Stage2 |
6.57409682247589E-11 |
| Normal-vs-Stage3 |
4.17554879561521E-13 |
| Normal-vs-Stage4 |
5.44009282066327E-14 |
| Stage1-vs-Stage2 |
9.586000E-01 |
| Stage1-vs-Stage3 |
1.571210E-01 |
| Stage1-vs-Stage4 |
2.429700E-02 |
| Stage2-vs-Stage3 |
3.608000E-01 |
| Stage2-vs-Stage4 |
7.817600E-02 |
| Stage3-vs-Stage4 |
2.771400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25044419263531E-12 |
| Normal-vs-AfricanAmerican |
1.02069999996512E-06 |
| Normal-vs-Asian |
3.80762088525444E-12 |
| Caucasian-vs-AfricanAmerican |
5.635200E-01 |
| Caucasian-vs-Asian |
4.553400E-01 |
| AfricanAmerican-vs-Asian |
3.589800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.73325806432467E-12 |
| Normal-vs-Female |
1.76869630053034E-12 |
| Male-vs-Female |
6.788200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.02822220024746E-12 |
| Normal-vs-Age(41-60Yrs) |
9.93316540132128E-13 |
| Normal-vs-Age(61-80Yrs) |
3.33288951992472E-12 |
| Normal-vs-Age(81-100Yrs) |
1.117700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.053800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.788000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.790800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.770000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.575000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.567600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.937400E-03 |
| Classical-VS-Follicular |
1.298820E-01 |
| Classical-VS-Other |
3.277200E-01 |
| Classical-VS-Normal |
6.92468304919203E-12 |
| Tall-VS-Follicular |
1.064230E-03 |
| Tall-VS-Other |
9.278600E-01 |
| Tall-VS-Normal |
2.70894418008538E-14 |
| Follicular-VS-Other |
1.996390E-01 |
| Follicular-VS-Normal |
6.38049946211083E-10 |
| Other-VS-Normal |
3.01510000300098E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.10926848104509E-12 |
| Normal-vs-N1 |
1.10750297821482E-11 |
| N0-vs-N1 |
5.512400E-01 |
|
|
